Trials / Completed
CompletedNCT01459575
Unboosted Atazanavir as Initial ART Therapy in China
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- —
- Sponsor
- National Center for AIDS/STD Control and Prevention, China CDC · Other Government
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label, Pilot study.The study hypothesis is that the feasibility and efficacy of a non-boosted ATV based HAART will be well as the first line treatment in a Chinese resource-limited setting.
Conditions
Timeline
- Start date
- 2005-07-01
- Primary completion
- 2005-12-01
- Completion
- 2006-12-01
- First posted
- 2011-10-25
- Last updated
- 2011-10-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01459575. Inclusion in this directory is not an endorsement.